Want to see IN:ROSSARI full AI Analyst Report?
Rossari Biotech Ltd (ROSSARI) Financial Statements
Rossari Biotech Ltd Financial Overview
Rossari Biotech Ltd's market cap is currently $22.12B. The company's EPS TTM is $27.58; its P/E ratio is 14.48; and it has a dividend yield of 0.13%. Rossari Biotech Ltd is estimated to report earnings on January 18, 2027, and the estimated EPS forecast is $7.20. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 23.96B | $ 20.80B | $ 18.31B | $ 16.56B | $ 14.83B |
| Gross Profit | $ 4.94B | $ 6.47B | $ 5.26B | $ 2.80B | $ 2.29B |
| Operating Income | $ 2.07B | $ 5.15B | $ 1.87B | $ 1.55B | $ 1.32B |
| EBITDA | $ 2.86B | $ 2.65B | $ 2.57B | $ 2.12B | $ 1.94B |
| Net Income | $ 1.49B | $ 1.36B | $ 1.31B | $ 1.07B | $ 976.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.27B | $ 1.14B | $ 667.85M | $ 1.52B | $ 644.26M |
| Total Assets | $ 22.89B | $ 18.96B | $ 15.72B | $ 13.68B | $ 12.57B |
| Total Debt | $ 4.36B | $ 2.18B | $ 1.19B | $ 739.28M | $ 84.27M |
| Net Debt | $ 3.44B | $ 1.61B | $ 936.22M | $ 40.96M | $ -290.50M |
| Total Liabilities | $ 9.55B | $ 7.11B | $ 5.24B | $ 4.52B | $ 4.52B |
| Stockholders' Equity | $ 13.33B | $ 11.85B | $ 10.48B | $ 9.15B | $ 8.05B |
| Cash Flow | |||||
| Free Cash Flow | $ -2.20B | $ -210.69M | $ -880.28M | $ 1.20B | $ -88.67M |
| Operating Cash Flow | $ 451.63M | $ 1.37B | $ 432.55M | $ 1.52B | $ 293.58M |
| Investing Cash Flow | $ -2.22B | $ -1.84B | $ -1.03B | $ -1.81B | $ -2.99B |
| Financing Cash Flow | $ 2.09B | $ 649.01M | $ 161.85M | $ 608.55M | $ 2.92B |
Currency in INR